Organization | Nazareth Hospital

Nazareth Hospital Report issue

Academic/Hospital Phase 2

Founded: Philadelphia PA United States (1996)

Organization Overview

First Clinical Trial

2010

NCT01238471

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2014

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 2 Trials (2)

propranolol (inderal) (1 trial)

sucrose (1 trial)

Drugs in Other Trials (4)

acetylcysteine (mucomyst) (1 trial)

heparin (liquaemin) (1 trial)

levocarnitine (carnitor) (3 trials)

mycophenolate (CellCept) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Premature Birth (Phase 2)

Retinal Diseases (Phase 2)

Retinopathy of Prematurity (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 5
# of Trial APIs: 6